Literature DB >> 30390811

Signs and Symptoms of Hypoparathyroidism.

Natalie E Cusano1, John P Bilezikian2.   

Abstract

Hypoparathyroidism is associated with a spectrum of clinical manifestations in the acute and chronic settings, from mild to debilitating. Although the acute symptoms of hypocalcemia are primarily due to neuromuscular irritability, the chronic manifestations of hypoparathyroidism may be due to the disease itself or to complications of therapy or to both. The chronic complications of hypoparathyroidism can affect multiple organ systems, including the renal, neurologic, neuropsychiatric, skeletal, and immune systems. Further research is needed to determine the pathophysiology of complications in hypoparathyroidism and whether interventions can decrease the risk of these complications.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Basal ganglia calcification; Cataract; Complication; Hypoparathyroidism; Renal failure

Mesh:

Year:  2018        PMID: 30390811     DOI: 10.1016/j.ecl.2018.07.001

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  5 in total

Review 1.  Hypoparathyroidism.

Authors:  John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

Review 2.  Diagnosis and management of hypocalcemia.

Authors:  Jessica Pepe; Luciano Colangelo; Federica Biamonte; Chiara Sonato; Vittoria Carmela Danese; Veronica Cecchetti; Marco Occhiuto; Valentina Piazzolla; Viviana De Martino; Federica Ferrone; Salvatore Minisola; Cristiana Cipriani
Journal:  Endocrine       Date:  2020-05-04       Impact factor: 3.633

3.  The Russian Registry of Chronic Hypoparathyroidism.

Authors:  Elena V Kovaleva; Anna K Eremkina; Alina R Elfimova; Julia A Krupinova; Ekaterina E Bibik; Irina S Maganeva; Anna M Gorbacheva; Ekaterina A Dobreva; Galina A Melnichenko; Natalia G Mokrysheva
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-16       Impact factor: 5.555

4.  Unrecognized Primary Hypoparathyroidism with Severe Hypocalcemia in the Presence of COVID-19 Infection.

Authors:  Domas Grigoravičius; Laura Šiaulienė; Žydrūnė Visockienė
Journal:  Acta Med Litu       Date:  2022-03-15

5.  PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism.

Authors:  Aliya A Khan; Lars Rejnmark; Mishaela Rubin; Peter Schwarz; Tamara Vokes; Bart Clarke; Intekhab Ahmed; Lorenz Hofbauer; Claudio Marcocci; Uberto Pagotto; Andrea Palermo; Erik Eriksen; Meryl Brod; Denka Markova; Alden Smith; Susanne Pihl; Sanchita Mourya; David B Karpf; Aimee D Shu
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 5.958

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.